2016년 3월 8일 14:35

Seegene Technologies to Unleash Customized Multiplex PCR Solutions and Support for U.S. Market

Seegene Technologies, Inc., a wholly-owned subsidiary of Seegene, Inc. (096530. KQ) , a global developer of multiplex molecular technologies and multiplex clinical molecular diagnostics (M-MoDx), is making Seegene’s proprietary multiplex PCR assay...